Literature DB >> 33571449

HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.

Kiera L Clayton1, Geetha Mylvaganam2, Alonso Villasmil-Ocando1, Heather Stuart1, Marcela V Maus3, Mohammad Rashidian4, Hidde L Ploegh5, Bruce D Walker6.   

Abstract

Natural killer (NK) cells are innate cytolytic effectors that target HIV-infected CD4+ T cells. In conjunction with antibodies recognizing the HIV envelope, NK cells also eliminate HIV-infected targets through antibody-dependent cellular cytotoxicity (ADCC). However, how these NK cell functions impact infected macrophages is less understood. We show that HIV-infected macrophages resist NK cell-mediated killing. Compared with HIV-infected CD4+ T cells, initial innate NK cell interactions with HIV-infected macrophages skew the response toward cytokine production, rather than release of cytolytic contents, causing inefficient elimination of infected macrophages. Studies with chimeric antigen receptor (CAR) T cells demonstrate that the viral envelope is equally accessible on CD4+ T cells and macrophages. Nonetheless, ADCC against macrophages is muted compared with ADCC against CD4+ T cells. Thus, HIV-infected macrophages employ mechanisms to evade immediate cytolytic NK cell function while preserving inflammatory cytokine responses. These findings emphasize the importance of eliminating infected macrophages for HIV cure efforts.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADCC; CAR T cells; HIV; HIV envelope; NK cells; macrophage; virus-containing compartment

Mesh:

Substances:

Year:  2021        PMID: 33571449      PMCID: PMC8486985          DOI: 10.1016/j.chom.2021.01.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  70 in total

1.  HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages.

Authors:  Mabel Jouve; Nathalie Sol-Foulon; Sarah Watson; Olivier Schwartz; Philippe Benaroch
Journal:  Cell Host Microbe       Date:  2007-08-16       Impact factor: 21.023

2.  Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART.

Authors:  Alberto Zalar; Maria Ines Figueroa; Beatriz Ruibal-Ares; Patricia Baré; Pedro Cahn; Maria Marta de E de Bracco; Liliana Belmonte
Journal:  Antiviral Res       Date:  2010-05-22       Impact factor: 5.970

3.  A general strategy for the evolution of bond-forming enzymes using yeast display.

Authors:  Irwin Chen; Brent M Dorr; David R Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-22       Impact factor: 11.205

4.  Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo.

Authors:  Claire Deleage; Marina Moreau; Nathalie Rioux-Leclercq; Annick Ruffault; Bernard Jégou; Nathalie Dejucq-Rainsford
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

5.  Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.

Authors:  Costin Tomescu; Domenico Mavilio; Luis J Montaner
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

6.  Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure.

Authors:  James M Kovacs; Erik Noeldeke; Heather Jiwon Ha; Hanqin Peng; Sophia Rits-Volloch; Stephen C Harrison; Bing Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

7.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

8.  Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system.

Authors:  Kiera L Clayton; David R Collins; Josh Lengieza; Musie Ghebremichael; Farokh Dotiwala; Judy Lieberman; Bruce D Walker
Journal:  Nat Immunol       Date:  2018-04-18       Impact factor: 25.606

9.  Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy.

Authors:  Allen Ko; Guobin Kang; Julian B Hattler; Hadiza I Galadima; Junfeng Zhang; Qingsheng Li; Woong-Ki Kim
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-07       Impact factor: 4.147

10.  Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.

Authors:  Manuela Fogli; Domenico Mavilio; Enrico Brunetta; Stefania Varchetta; Khaled Ata; Gregg Roby; Colin Kovacs; Dean Follmann; Daniela Pende; Jeffrey Ward; Edward Barker; Emanuela Marcenaro; Alessandro Moretta; Anthony S Fauci
Journal:  PLoS Pathog       Date:  2008-07-11       Impact factor: 6.823

View more
  9 in total

1.  Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity.

Authors:  Rebecca J Peters; Mario Stevenson
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

Review 2.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

Review 3.  Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies.

Authors:  Min Chen; Min Li; Marietta M Budai; Andrew P Rice; Jason T Kimata; Mahesh Mohan; Jin Wang
Journal:  J Leukoc Biol       Date:  2022-03-31       Impact factor: 6.011

4.  Plasma antibodies from humans infected with zoonotic simian foamy virus do not inhibit cell-to-cell transmission of the virus despite binding to the surface of infected cells.

Authors:  Mathilde Couteaudier; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Antoine Gessain; Florence Buseyne
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

Review 5.  Persistent Inflammation and Non-AIDS Comorbidities During ART: Coming of the Age of Monocytes.

Authors:  Ruojing Bai; Zhen Li; Shiyun Lv; Ran Wang; Wei Hua; Hao Wu; Lili Dai
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 6.  NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses.

Authors:  Leonore Mensching; Angelique Hoelzemer
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

7.  TCR-mimic bispecific antibodies to target the HIV-1 reservoir.

Authors:  Srona Sengupta; Nathan L Board; Fengting Wu; Milica Moskovljevic; Jacqueline Douglass; Josephine Zhang; Bruce R Reinhold; Jonathan Duke-Cohan; Jeanna Yu; Madison C Reed; Yasmine Tabdili; Aitana Azurmendi; Emily J Fray; Hao Zhang; Emily Han-Chung Hsiue; Katharine Jenike; Ya-Chi Ho; Sandra B Gabelli; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou; Janet D Siliciano; Scheherazade Sadegh-Nasseri; Ellis L Reinherz; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-08       Impact factor: 12.779

8.  Development of a Novel In Vitro Primary Human Monocyte-Derived Macrophage Model To Study Reactivation of HIV-1 Transcription.

Authors:  Anna C Hearps; Anthony Jaworowski; Michelle E Wong; Chad J Johnson
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

9.  TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4+ T Cells.

Authors:  Siqin Duan; Xinfeng Xu; Jinshen Wang; Liwen Huang; Jie Peng; Tao Yu; Yang Zhou; Kui Cheng; Shuwen Liu
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.